Tag - medicine

 
 

MEDICINE

Japan Times
WORLD / Science & Health
Dec 9, 2020
China’s state-backed coronavirus vaccine has 86% efficacy, says UAE
China’s state-backed coronavirus vaccine protected 86% of people from getting COVID-19 in trials conducted in the United Arab Emirates, reported media outlets including Reuters, citing the UAE’s health ministry.
Japan Times
COMMENTARY / World
Dec 9, 2020
The pandemic public-debt dilemma
Extraordinary times call for extraordinary measures. Failing bold action, developing countries could be on track to lose years or even decades of progress in the post-pandemic world.
Japan Times
COMMENTARY / World
Dec 9, 2020
How to vaccinate a nation of skeptics against COVID-19
How to convince people to actually take the shot. Achieving herd immunity may mean at least 80% of people will need the vaccine.
Japan Times
WORLD / Science & Health
Dec 9, 2020
Testing times: More work needed on AstraZeneca/Oxford vaccine trials
A Lancet study gave few extra clues about why efficacy was 62% for trial participants given two full doses, but 90% for a smaller subgroup given a half, then a full dose.
Japan Times
WORLD
Dec 6, 2020
With Pfizer's COVID-19 shot, Britain prepares for world-first vaccine rollout
Britain gave emergency use approval for the vaccine last week — jumping ahead in the global race to begin the most crucial mass inoculation program in history.
Japan Times
COMMENTARY / World
Dec 4, 2020
COVID-19: Nobody is safe until everyone is safe
A recent study projected that unequal global distribution of COVID-19 vaccines could cost the world economy up to $1.2 trillion.
Japan Times
COMMENTARY / World
Dec 2, 2020
Language and lockdowns amid the pandemic
Reducing the issue to a binary question (Should we lock down or not?), or even a linear one (How much should we lock down?), oversimplifies a complicated problem.
Japan Times
COMMENTARY / World
Dec 1, 2020
A triumph of German innovation and immigration
The great advantage of BioNTech's approach is that it allows for the production of more than one billion vaccine doses within the space of just a few months.
Japan Times
WORLD
Nov 30, 2020
Moderna to seek U.S. and EU clearance for COVID-19 vaccine
The move came after a new analysis showed the vaccine was highly effective in preventing COVID-19 with no serious safety problems.
Japan Times
WORLD / Science & Health
Nov 29, 2020
COVID-19 drugs from Lilly and Regeneron raise access and timing concerns
Powerful drugs recently authorized by the U.S. that may prevent those at the earliest stages of COVID-19 from suffering severe disease present thorny new challenges, including who will get them and where they’ll be administered.
Japan Times
JAPAN / Science & Health
Nov 27, 2020
Ratio of medical staff gives Japan edge against COVID-19, OECD says
The nation is also helped by its better infrastructure, higher numbers of intensive care beds and higher government spending as a proportion of GDP.
Japan Times
COMMENTARY / World
Nov 27, 2020
Coronavirus is helping African economies compete
Africa's 54 countries now include seven of the globe's 10 fastest-growing economies, in part because the lethal virus may have improved their competitive advantage.
Japan Times
WORLD / Science & Health
Nov 26, 2020
After admitting error, AstraZeneca faces hard questions on vaccine
Scientists said a series of irregularities and omissions in the way AstraZeneca initially disclosed the data have eroded their confidence in the reliability of the results.
Japan Times
COMMENTARY / World
Nov 26, 2020
What a 95% effective vaccine could do is pretty exciting
A rough estimate based on the infectiousness of COVID-19 is that about 70% of the population would have to be immune for its spread to slow without any other preventative measures.
Japan Times
JAPAN / Science & Health
Nov 25, 2020
Not so fast, Japan experts say, as COVID-19 vaccines raise hopes
Medical experts say long-term safety and efficacy concerns remain as the vaccines are developed in record-setting time.
Japan Times
WORLD / Science & Health
Nov 25, 2020
Evidence builds that an early mutation made the pandemic harder to stop
There is no evidence that a coronavirus with the mutation causes more severe symptoms, kills more people or complicates the development of vaccines.
Japan Times
WORLD / Science & Health / FOCUS
Nov 24, 2020
Decades of work, and half a dose of fortune, drove Oxford vaccine success
The Oxford vaccinologists were exhilarated on Monday when drugmaker AstraZeneca, with whom they developed the shot, announced that it could be around 90% effective.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?